According to
the latest report by IMARC Group “Blood Culture Test Market: Global Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The
global blood culture test market reached a value of US$ 4.2 Billion in
2020. Looking forward, IMARC Group expects the market to grow at a CAGR of
around 9% during 2021-2026.
A blood culture
test is used to check foreign invaders like yeast, bacteria, and other
microorganisms in the blood. It relies on the blood sample of an individual
obtained via sterile technique, which is kept in culture media and incubated in
a controlled environment for a few days. the results help in determining the
pathogens causing the infection and possible methods for combating the disease.
Market Trends:
The global
market is primarily driven by the rising incidences of bloodstream infections
(BSI), sepsis and environment-borne diseases. Besides this, the increasing
prevalence of chronic diseases, especially among the geriatric population,
which is relatively more prone to medical ailments, is also contributing to the
market growth. Furthermore, leading players are focusing on launching novel
diagnostic techniques to reduce diagnosis time, eliminate manual errors and
offer early prevention of infections. This, along with the rising cases of
coronavirus disease (COVID-19), is escalating the demand for blood culture
tests, thereby supporting the market growth.
Request for a free sample copy of this report: https://www.imarcgroup.com/blood-culture-test-market/requestsample
We are regularly tracking the direct effect of
COVID-19 on the market, along with the indirect influence of associated
industries. These observations will be integrated into the report.
Competitive
Landscape:
The competitive
landscape of the market has been studied in the report with the detailed
profiles of the key players operating in the market.
Some of these
key players include:
- Abbott Laboratories (ABT)
- Beckman Coulter ( BEC )
- BD (Becton, Dickinson and
Company) (NYSE:BDX)
- BIOMERIEUX (BIM.PA)
- Bruker Corporation (BRKR)
- Cepheid (NASDAQ:CPHD). (Danaher
Corporation)
- Luminex Corporation
- Merck Group
- Siemens Healthineers AG
- Roche Diagnostics
- T2 Biosystems, Inc. (TTOO)
- Thermo Fisher Scientific Inc. (NYSE: TMO)
Explore full
report with table of contents: https://www.imarcgroup.com/blood-culture-test-market
The report has
segmented the market on the basis of Product Type, End-User and Region.
Breakup by
Testing Method:
- Conventional
- Automated
Breakup by
Product:
- Consumables
- Blood Culture Media
- Aerobic
Blood Culture Media
- Anaerobic
Blood Culture Media
- Fungi/Yeast
Blood Culture Media
- Mycobacteria
Blood Culture Media
- Assay Kits and Reagents
- Blood Culture Accessories
- Instruments
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Incubators
- Colony
Counters
- Microscopes
- Gram
Stainers
- Software and Services
Breakup by
Technology:
- Culture-based Technology
- Molecular Technology
- Microarray
- PCR
- PNA-FISH
- Proteomic Technology
- Others
Breakup by Application:
- Bacterial Infection
- Fungal Infection
- Mycobacterial Infection
Breakup by
End-User:
- Hospital Laboratories
- Reference Laboratories
- Research Laboratories
- Others
Market Breakup
by Region:
- North America (United States,
Canada)
- Asia Pacific (China, Japan, India,
South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United
Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico,
Others)
- Middle East and Africa
If you want
latest primary and secondary data (2021-2026) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours of receiving full payment.
About Us
IMARC Group is
a leading market research company that offers management strategy and market
research worldwide. We partner with clients in all sectors and regions to
identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC's
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company's expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800